首页> 外文期刊>The Indian journal of medical research. >Sickle cell disease in tribal populations in India
【24h】

Sickle cell disease in tribal populations in India

机译:在印度部落群体的镰状细胞病

获取原文
获取原文并翻译 | 示例
       

摘要

The sickle gene is widespread among many tribal population groups in India with prevalence of heterozygotes varying from 1-40 per cent. Co-inheritance of the sickle gene with -thalassaemia, HbD Punjab and glucose-6-phosphate dehydrogenase (G6PD) deficiency has also been reported. Most of the screening programmes in India now use high performance liquid chromatography (HPLC) analysis although the solubility test is also sensitive and cheap. Sickle cell disease (SCD) among tribal populations is generally milder than among non-tribal groups with fewer episodes of painful crises, infections, acute chest syndrome and need for hospitalization. This has partly been attributed to the very high prevalence of -thalassaemia among these tribes as well as higher foetal haemoglobin levels. However, the clinical presentation is variable with many cases having a severe presentation. There is not much information available on maternal and perinatal outcome in tribal women with sickle cell disease. Newborn screening programmes for SCD have recently been initiated in Maharashtra, Gujarat, Orissa and Chattisgarh and monitoring these birth cohorts will help to understand the natural history of SCD in India. Prenatal diagnosis is acceptable by tribal families in India. The Indian Council of Medical Research and the National Rural Health Mission in different States are undertaking outreach programmes for better management and control of the disease.
机译:镰刀基因在印度的许多部族人群中普遍存在,杂合子患病率从1-40%之间变化。据报道,镰刀基因的共同遗传,HBD旁遮普和葡萄糖-6-磷酸脱氢酶(G6PD)缺乏症。印度的大多数筛查程序现在使用高效液相色谱(HPLC)分析,尽管溶解度测试也很敏感且便宜。部落群体中的镰状细胞疾病(SCD)通常比非部落群体中更温和,痛苦的危机,感染,急性胸综合征,需要住院和住院。这部分归因于这些部落之间的高分症患病率以及胎儿血红蛋白水平较高。然而,临床介绍是可变的,许多患者具有严重呈现。在镰状细胞疾病的部族妇女的孕产妇和围产期结果上没有多少信息。新生儿SCD筛查计划最近在马哈拉施特拉,古吉拉特邦,奥里萨邦和Chattisgarh发起,并监测这些出生队列将有助于了解印度SCD的自然历史。印度部落家庭可以接受产前诊断。印度医学研究委员会和国家农村健康使命在不同国家正在开展外联方案,以更好地管理和控制该疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号